|
1
|
Menis M, Anderson SA, Forshee RA, McKean
S, Johnson C, Warnock R, Gondalia R, Mintz PD, Holness L, Worrall
CM, et al: Transfusion-related acute lung injury and potential risk
factors among the inpatient US elderly as recorded in Medicare
claims data, during 2007 through 2011. Transfusion. 54:2182–2193.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abraham E: Neutrophils and acute lung
injury. Crit Care Med. 31:S195–S199. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fielhaber JA, Carroll SF, Dydensborg AB,
Shourian M, Triantafillopoulos A, Harel S, Hussain SN, Bouchard M,
Qureshi ST and Kristof AS: Inhibition of mammalian target of
rapamycin augments lipopolysaccharide-induced lung injury and
apoptosis. J Immunol. 188:4535–4542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mossman JA, Biancani LM, Zhu CT and Rand
DM: Mitonuclear Epistasis for Development Time and Its Modification
by Diet in Drosophila. Genetics. 203:463–484. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sharif R, Dawra R, Wasiluk K, Phillips P,
Dudeja V, Kurt-Jones E, Finberg R and Saluja A: Impact of toll-like
receptor 4 on the severity of acute pancreatitis and
pancreatitis-associated lung injury in mice. Gut. 58:813–819. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuan YE, Liwei L and Zhiqiang L: Effects
of rapamycin on expressions of m TOR down-stream proteins
p70s6k/p-p70s6k and pulmonary histopathological changes in
transfusion-related acute lung injury rat model. Chin J Blood
Transfus. 29:251–254. 2016.
|
|
7
|
Hay N and Sonenberg N: Upstream and
downstream of mTOR. Genes Dev. 18:1926–1945. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tee AR and Blenis J: mTOR, translational
control and human disease. Semin Cell Dev Biol. 16:29–37. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng T, Golub TR and Sabatini DM: The
immunosuppressant rapamycin mimics a starvation-like signal
distinct from amino acid and glucose deprivation. Mol Cell Biol.
22:5575–5584. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jacinto E, Loewith R, Schmidt A, Lin S,
Rüegg MA, Hall A and Hall MN: Mammalian TOR complex 2 controls the
actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol.
6:1122–1128. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheretakis C, Dror Y and Glogauer M: A
noninvasive oral rinse assay to monitor engraftment, neutrophil
tissue delivery and susceptibility to infection following HSCT in
pediatric patients. Bone Marrow Transplant. 36:227–232.
2005.PubMed/NCBI
|
|
12
|
Fialkow L, Filho L Fochesatto, Bozzetti
MC, Milani AR, Filho EM Rodrigues, Ladniuk RM, Pierozan P, de Moura
RM, Prolla JC, Vachon E, et al: Neutrophil apoptosis: A marker of
disease severity in sepsis and sepsis-induced acute respiratory
distress syndrome. Crit Care. 10:R1552006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin WC, Lin CF, Chen CL, Chen CW and Lin
YS: Inhibition of neutrophil apoptosis via sphingolipid signaling
in acute lung injury. J Pharmacol Exp Ther. 339:45–53. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perl M, Hohmann C, Denk S, Kellermann P,
Lu D, Braumüller S, Bachem MG, Thomas J, Knöferl MW, Ayala A, et
al: Role of activated neutrophils in chest trauma-induced septic
acute lung injury. Shock. 38:98–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Li C, Liang W, Bi Y, Chen M and Dong
S: Protectin D1 promotes resolution of inflammation in a murine
model of lipopolysaccharide-induced acute lung injury via enhancing
neutrophil apoptosis. Chin Med J (Engl). 127:810–814.
2014.PubMed/NCBI
|
|
16
|
Shi W, Wei X, Wang Z, Han H, Fu Y, Liu J,
Zhang Y, Guo J, Dong C, Zhou D, et al: HDAC9 exacerbates
endothelial injury in cerebral ischaemia/reperfusion injury. J Cell
Mol Med. 20:1139–1149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Urbanek T, Kuczmik W, Basta-Kaim A and
Gabryel B: Rapamycin induces of protective autophagy in vascular
endothelial cells exposed to oxygen-glucose deprivation. Brain Res.
1553:1–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lorne E, Zhao X, Zmijewski JW, Liu G, Park
YJ, Tsuruta Y and Abraham E: Participation of mammalian target of
rapamycin complex 1 in Toll-like receptor 2- and 4-induced
neutrophil activation and acute lung injury. Am J Respir Cell Mol
Biol. 41:237–245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yen YT, Yang HR, Lo HC, Hsieh YC, Tsai SC,
Hong CW and Hsieh CH: Enhancing autophagy with activated protein C
and rapamycin protects against sepsis-induced acute lung injury.
Surgery. 153:689–698. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen D, Ma T, Liu XW, Yang C and Liu Z:
Rapamycin reverses paraquat-induced acute lung injury in a rat
model through inhibition of NFκB activation. Int J Clin Exp Pathol.
8:4627–4638. 2015.PubMed/NCBI
|
|
21
|
Taneja R, Parodo J, Jia SH, Kapus A,
Rotstein OD and Marshall JC: Delayed neutrophil apoptosis in sepsis
is associated with maintenance of mitochondrial transmembrane
potential and reduced caspase-9 activity. Crit Care Med.
32:1460–1469. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Neill S, O'Neill AJ, Conroy E, Brady HR,
Fitzpatrick JM and Watson RW: Altered caspase expression results in
delayed neutrophil apoptosis in acute pancreatitis. J Leukoc Biol.
68:15–20. 2000.PubMed/NCBI
|
